Artery Research

Volume 24, Issue C, December 2018, Pages 113 - 113

P118 CXCL13 AS A NOVEL POTENTIAL BIOMARKER OF ESSENTIAL HYPERTENSION

Authors
Yanina Timasheva, Vera Erdman, Timur Nasibullin, Ilsiyar Tuktarova, Olga Mustafina
Institute of Biochemistry and Genetics IFRC RAS, Ufa, Russia
Available Online 4 December 2018.
DOI
10.1016/j.artres.2018.10.171How to use a DOI?
Abstract

Background: Arterial hypertension is the main modifiable risk factor of cardiovascular disease. Inflammation and endothelial dysfunction contribute to arterial wall remodeling and blood pressure elevation, leading to the development of age-associated changes of cardiovascular system that limit the lifespan.

Objectives: Our aim was to explore the role of inflammatory mediators in blood pressure regulation, and to identify potential biomarkers of essential hypertension (EH) in the study group including individuals with enhanced survival (beyond 80 years).

Methods: We performed gene expression analysis in peripheral blood leukocytes of EH patients and healthy individuals using RT2 Profiler PCR Array (Qiagen) in the group of 30 EH patients and 32 control subjects aged between 30 and 60 years, and 12 individuals aged between 82 and 113 years (6 EH patients, 6 normotensive controls). Next, we performed genotyping of polymorphic markers located in differentially expressed genes, and analysed associations with EH in the study group consisting of 1724 individuals aged between 30 and 108 years.

Results: In the group of middle-aged hypertensive patients, we found altered transcriptional activity of 21 gene. Relative expression level changes in EH patients were more pronounced for CXCL13 (13.8-fold), IL1F6 (12.9-fold), CD40LG (8-fold), CXCL1 (7.2-fold). In the elderly hypertensive individuals compared to healthy controls, transcriptional activity of NFKB1 and IL18R1 genes was increased (FC, fold change, 3.21 and 2.41, respectively, P<0.05). The association analysis demonstrated the association between EH and CXCL13 rs355689*C allele (OR = 0.61, PBonf = 5*10−4).

Conclusions: Our results suggest that CXCL13 might contribute to the development of hypertension.

Open Access
This is an open access article distributed under the CC BY-NC license.

Journal
Artery Research
Volume-Issue
24 - C
Pages
113 - 113
Publication Date
2018/12/04
ISSN (Online)
1876-4401
ISSN (Print)
1872-9312
DOI
10.1016/j.artres.2018.10.171How to use a DOI?
Open Access
This is an open access article distributed under the CC BY-NC license.

Cite this article

TY  - JOUR
AU  - Yanina Timasheva
AU  - Vera Erdman
AU  - Timur Nasibullin
AU  - Ilsiyar Tuktarova
AU  - Olga Mustafina
PY  - 2018
DA  - 2018/12/04
TI  - P118 CXCL13 AS A NOVEL POTENTIAL BIOMARKER OF ESSENTIAL HYPERTENSION
JO  - Artery Research
SP  - 113
EP  - 113
VL  - 24
IS  - C
SN  - 1876-4401
UR  - https://doi.org/10.1016/j.artres.2018.10.171
DO  - 10.1016/j.artres.2018.10.171
ID  - Timasheva2018
ER  -